Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > No follow through

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jan 11, 2021 2:35pm

257 Views

Post# 32268612

RE:No follow through

Sigilon skyrockets? Really? Looks like it's trading close to the lowest it's been. Nasdaq listing is a bad idea IMO. They will roll the shares back to get the price up. Problem here is lack of news via official channels. SVA is always propelled with rumors and inside info. Once the news eventually comes out, it's no longer news and the price suffers. Need updates on clinical, where we are with Hemo clinical application, thyroid clinical application, etc etc.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide